Possible risk modifications in the association between MnSOD Ala-9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial

Author： Chen Yun  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.125, Iss.2, 2011-01, pp. : 495-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects

By Qiu Li-Xin  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 543-547

Springer Publishing Company

Access to resources Recommend Favorite

No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls

By Ma Xiangyu  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 509-514

Springer Publishing Company

Access to resources Recommend Favorite

MnSOD Val-9Ala Genotype, Pro- and Anti-oxidant Environmental Modifiers, and Breast Cancer Among Women on Long Island, New York

By Gaudet Mia  

Cancer Causes and Control, Vol. 16, Iss. 10, 2005-12 ,pp. : 1225-1234

Springer Publishing Company

Access to resources Recommend Favorite

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite

Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis

By Chen Yun   Pei Jianping  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 471-481

Springer Publishing Company

Access to resources Recommend Favorite